New Draft Decision Seeks To Deepen Analysis On WHO Pandemic Flu Framework 24/05/2017 Catherine Saez A new draft decision submitted this week at the World Health Assembly (WHA) by a group of countries would set out further actions to analyse the Pandemic Influenza Preparedness (PIP) Framework. Continue reading -> Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
Antimicrobial Resistance Needs New R&D Models, NGOs Say 24/05/2017 Catherine Saez A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control. Continue reading -> NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
NCD Alliance Event: Time For Action Against Noncommunicable Diseases 24/05/2017 Elise De Geyter It might be said it is a “golden moment” for fighting noncommunicable diseases. There have never been as many side events on noncommunicable diseases during the World Health Assembly as this year, according to speakers at an event of the NCD Alliance this week. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs 04/05/2017 Catherine Saez A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading -> WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
WHO Election FAQ What is the WHO Director-General election? The Director-General is WHO’s chief technical and administrative officer. Member States elect the next Director-General through a formal process led by the WHO Executive Board and the World Health Assembly. The current term ends on 15 August 2027; the next Director-General is due to take office on 16 August […] Continue reading -> As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
As WHO Nominations For Next Director-General Close, Six Contenders Emerge – But More May Remain Under Seal 25/09/2026 Felix Sassmannshausen Following the statutory WHO nomination deadline for the next Director-General, six candidates have now been publicly declared on the agency’s prospective candidate page. While oncologist Dr Gevorg Tamamyan has been proposed in a cross-regional nomination by Botswana, sources with knowledge of the process said Gavi CEO Dr Sania Nishtar was reportedly not nominated by Pakistan. […] Continue reading -> EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: Spain to Nominate María Neira as Candidate for WHO Director-General 23/09/2026 Felix Sassmannshausen Spain has officially submitted Dr María Neira’s nomination for the WHO Director-General election ahead of Thursday’s statutory deadline, sources close to the matter told Health Policy Watch. The submission expands the candidate pool by introducing a focus on primary prevention and climate-related health risks to the race. Before Neira’s nomination, a coalition representing over 100 […] Continue reading -> Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks 14/09/2026 Kerry Cullinan Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading -> As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts
As Pandemic Talks Resume, EU Diplomat Sharply Criticises ‘Ideological Polarisation’ 11/09/2026 Felix Sassmannshausen & Kerry Cullinan EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading -> Posts navigation Older postsNewer posts